Certain piperazinyl and piperidinyl urea compounds are useful as FAAH inhibitors. Such compounds may be used in pharmaceutical compositions and methods for the treatment of disease states, disorders, and conditions mediated by fatty acid amide hydrolase (FAAH) activity. Thus, the compounds may be administered to treat, e.g., anxiety, pain, inflammation, sleep disorders, eating disorders, or movement disorders (such as multiple sclerosis).

 
Web www.patentalert.com

< Power supply monitoring for an implantable device

< System and method for simultaneously optimizing the quality of life and controlling health care costs

> Bis-aryl thiazole derivatives

> Novel uses of prostaglandin d2, prostaglandin d2 agonist and prostaglandin d2 antagonist

~ 00279